The LFB Group
LFB is a biopharmaceutical group specialising in the development, production and marketing of plasma-derived medicinal products and recombinant proteins, mainly intended for patients suffering from serious and most often very rare pathologies.
In 2025, the LFB group markets some fifteen biomedicinal products in more than 30 countries, thanks to more than 2,900 employees committed to fulfilling the group's primary mission.
In 2025, the LFB group markets some fifteen biomedicinal products in more than 30 countries, thanks to more than 2,900 employees committed to fulfilling the group's primary mission.
The group in a few figures
-
+2,900employees worldwide in 2024
-
-
5bioproduction sites worldwide
-
-
3therapeutic areas
A leading player in Europe
Created in 1994 in France, LFB is now a leading industrial player in Europe that manufactures plasma-derived medicinal products for healthcare professionals.
It is with great pride that the LFB Group fulfils its mission of providing new treatment options for patients, in three major therapeutic areas: